Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Gryrotonic Training in Behcet-diseased Elders With Breast Cancer

5 november 2026 uppdaterad av: Ali Mohamed Ali ismail, Cairo University

gryrotonic training may be a good exercise modality in Behcet-diseased elders with breast cancer

Studieöversikt

Status

Rekrytering

Betingelser

Intervention / Behandling

Detaljerad beskrivning

forty Behcet-diseased elders with breast cancer will randomy divide into group I (receive gyrotonic exercise three session weekly for 12 week) or group II (wait list)

Studietyp

Interventionell

Inskrivning (Beräknad)

40

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

  • Egypten
    • Dokki
      • Giza, Dokki, Egypten
        • Rekrytering
        • Cairo University
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

65 år till 75 år (Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Kvinna

Beskrivning

Inclusion Criteria:

  • beast cancer survivors
  • behcet diseas patients

Exclusion Criteria:

  • cardiac or repiratory or renal failure patients

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: group number 1

twenty Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will 45 min
Beteende: exercise

twnety Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will last for 45 min
Inget ingripande: group number 2

twenty Behcet-diseased elders who survivied from breast cancer will be wait list for 12 weeks

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Short Physical Performance Battery
Tidsram: it will be measured after 12 weeks

the total score will be calcualted
it will be measured after 12 weeks

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Dual task gait speed
Tidsram: It will be measured after 12 weeks

this task assess gait speed
It will be measured after 12 weeks
Four-square step test
Tidsram: It will be measured after 12 weeks

it is fucntional balnce test
It will be measured after 12 weeks
grip strenghts
Tidsram: It will be measured after 12 weeks

it is a measure of grip strenghths in dominant hand
It will be measured after 12 weeks
time up- and go testing
Tidsram: It will be measured after 12 weeks

it is a measure of fall risk
It will be measured after 12 weeks
sit-to-stand 30-second testing
Tidsram: It will be measured after 12 weeks

asess number of repteations of sit-to-staning in 30 seconds
It will be measured after 12 weeks
six minute walking testingg
Tidsram: It will be measured after 12 weeks

distance covered by subject in six minutes wil be assessed
It will be measured after 12 weeks
10-meters walking testing
Tidsram: It will be measured after 12 weeks

time covered for walking for ten meter will be assessed
It will be measured after 12 weeks
trunk-flexor McGill core endurance test
Tidsram: It will be measured after 12 weeks

this test will assess endurance of trunk flexors
It will be measured after 12 weeks
trunk-extensor McGill core endurance test
Tidsram: It will be measured after 12 weeks

this test will assess endurance of trunk extensors
It will be measured after 12 weeks
right-lateral-trunk-bending McGill core endurance test
Tidsram: It will be measured after 12 weeks

this test will assess endurance of right lateral trunk bendors
It will be measured after 12 weeks
left-lateral-trunk-bending McGill core endurance test
Tidsram: It will be measured after 12 weeks

this test will assess endurance of left lateral trunk bendors
It will be measured after 12 weeks
arm flexion in thrity seconds
Tidsram: It will be measured after 12 weeks

it will assess numbers (repeations) of arm flexion in thirty second
It will be measured after 12 weeks
maximal nubmer of push up
Tidsram: It will be measured after 12 weeks

this will assess maximal number of performed psh ups in speciifc time
It will be measured after 12 weeks
behcet disease quality of life
Tidsram: It will be measured after 12 weeks

questioanire that will assess life quality in behcet disease (total score will be estiamted)
It will be measured after 12 weeks
total score of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess quality of life
It will be measured after 12 weeks
physical fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess physical fucntion related quality of life
It will be measured after 12 weeks
role fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess role fucntion related quality of life
It will be measured after 12 weeks
emotional fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess emotional fucntion related quality of life
It will be measured after 12 weeks
cognitive fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess cognitive fucntion related quality of life
It will be measured after 12 weeks
social fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess social fucntion related quality of life
It will be measured after 12 weeks
fatigue fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess fatigue
It will be measured after 12 weeks
nausea-vomiting subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it is a questioaire asess nausea-vomiting
It will be measured after 12 weeks
pain subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it will assess pain
It will be measured after 12 weeks
dyspnea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it will assess dyspnea
It will be measured after 12 weeks
insomnia subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it will assess insomnia
It will be measured after 12 weeks
appetite-loss subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it will assess appetite loss
It will be measured after 12 weeks
constipation subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it will assess constipation
It will be measured after 12 weeks
diarrhea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it will assess diarrhea
It will be measured after 12 weeks
financial difficulties subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsram: It will be measured after 12 weeks

it will assess financial difficulties
It will be measured after 12 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Cairo University

Utredare

  • Huvudutredare: Ali MA Ismail, phd, Cairo University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

30 november 2026

Primärt slutförande (Beräknad)

30 maj 2027

Avslutad studie (Beräknad)

30 maj 2027

Studieregistreringsdatum

Först inskickad

5 november 2026

Först inskickad som uppfyllde QC-kriterierna

5 november 2026

Första postat (Faktisk)

10 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

10 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

5 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • IRB00014233-118

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera